These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 1231479)

  • 1. Immunological aspects of halothane hepatitis. Possible relevance of biotransformation.
    Walton B
    Acta Anaesthesiol Belg; 1975; 23 Suppl():155-9. PubMed ID: 1231479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proceedings: Further immunological investigations in patients with possible halothane hepatitis.
    Walton B; Hamblin A; Dumonde DC; Simpson BR
    Br J Anaesth; 1975 Aug; 47(8):908-9. PubMed ID: 1201183
    [No Abstract]   [Full Text] [Related]  

  • 3. Absence of cellular hypersensitivity in patients with unexplained hepatitis following halothane.
    Walton B; Hamblin A; Dumonde DC; Simpson R
    Anesthesiology; 1976 May; 44(5):391-7. PubMed ID: 1267204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Halothane hepatitis].
    Dentan M; Desmonts JM; Berthelot P
    Presse Med (1893); 1971 Jun; 79(28):1285-8. PubMed ID: 5563076
    [No Abstract]   [Full Text] [Related]  

  • 5. Halothane: clinical considerations.
    Morley TS
    Int Anesthesiol Clin; 1974; 12(2):73-84. PubMed ID: 4603053
    [No Abstract]   [Full Text] [Related]  

  • 6. Lymphocyte stimulation induced by halothane in patients with hepatitis following exposure to halothane.
    Paronetto F; Popper H
    N Engl J Med; 1970 Aug; 283(6):277-80. PubMed ID: 5448331
    [No Abstract]   [Full Text] [Related]  

  • 7. Sensitisation to halothane-altered liver components in severe hepatic necrosis after halothane anaesthesia.
    Vergani D; Tsantoulas D; Eddleston AL; Davis M; Williams R
    Lancet; 1978 Oct; 2(8094):801-3. PubMed ID: 81359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of a cellular immune response in halothane-exposed guinea pigs.
    Furst SM; Luedke D; Gaw HH; Reich R; Gandolfi AJ
    Toxicol Appl Pharmacol; 1997 Apr; 143(2):245-55. PubMed ID: 9144442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Halothane immunity and hepatitis].
    Aji T; Shiaku Y; Kosaka N
    Masui; 1975 May; 24(5):421-9. PubMed ID: 1172015
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diagnostic tests for hypersensitivity to halogen compounds].
    Mathieu A; Di Padua D
    Ann Anesthesiol Fr; 1976; 17(3):295-8. PubMed ID: 1078533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Halothane hepatitis".
    Hehre FW
    Conn Med; 1974 Jun; 38(6):307-8. PubMed ID: 4831387
    [No Abstract]   [Full Text] [Related]  

  • 12. Biochemical effects of halothane.
    Acta Anaesthesiol Scand Suppl; 1972; 49():1-43. PubMed ID: 4568644
    [No Abstract]   [Full Text] [Related]  

  • 13. Cell-mediated immunity in halothane hypersensitivity.
    Doniach D
    N Engl J Med; 1970 Aug; 283(6):315-6. PubMed ID: 5427061
    [No Abstract]   [Full Text] [Related]  

  • 14. Experimental immunity to a metabolite of halothane and fluroxene: cutaneous delayed-type hypersensitivity.
    Mathieu A; DiPadua D; Mills J; Kahan B
    Anesthesiology; 1974 Apr; 40(4):385-90. PubMed ID: 4150486
    [No Abstract]   [Full Text] [Related]  

  • 15. [Test of lymphocyte transformation in 2 cases of hepatitis after anesthesia with halothane].
    Mathieu A; Walzer S
    Anesth Analg (Paris); 1973; 30(1):109-16. PubMed ID: 4721988
    [No Abstract]   [Full Text] [Related]  

  • 16. Human hepatocytes express trifluoroacetylated neoantigens after in vitro exposure to halothane.
    Ilyin GP; Rissel M; Malledant Y; Tanguy M; Guillouzo A
    Biochem Pharmacol; 1994 Aug; 48(3):561-7. PubMed ID: 8068043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Halothane hepatitis: a model of immune mediated drug hepatotoxicity.
    Neuberger J; Kenna JG
    Clin Sci (Lond); 1987 Mar; 72(3):263-70. PubMed ID: 3545644
    [No Abstract]   [Full Text] [Related]  

  • 18. Lymphocyte transformation. Absence of increased responses in alleged halothane jaundice.
    Walton B; Dumonde DC; Williams C; Jones D; Strunin JM; Layton JM; Strunin L; Simpson R
    JAMA; 1973 Jul; 225(5):494-8. PubMed ID: 4740337
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolic basis for a drug hypersensitivity: antibodies in sera from patients with halothane hepatitis recognize liver neoantigens that contain the trifluoroacetyl group derived from halothane.
    Kenna JG; Satoh H; Christ DD; Pohl LR
    J Pharmacol Exp Ther; 1988 Jun; 245(3):1103-9. PubMed ID: 3385639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Halothane hepatitis patients have serum antibodies that react with protein disulfide isomerase.
    Martin JL; Kenna JG; Martin BM; Thomassen D; Reed GF; Pohl LR
    Hepatology; 1993 Oct; 18(4):858-63. PubMed ID: 8406360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.